TissueTinker’s bioprinted tumors offer new cancer drug testing model
Secure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense! McGill University’s spinout TissueTinker is exploring a new bioprinting approach that could improve the way cancer drugs are tested in preclinical settings. Co-founded by Benjamin Ringler, Madison Santos, and Isabelle Dummer, the startup recently received a Develop […]
Go to Source
Author: Ada Shaikhnag
